Dry Eye Treatment in Gurgaon

Many people with dry eye are told their eyes are “normal” even while struggling with burning, fluctuating vision, eye strain, or discomfort during screen use. Advanced dry eye evaluation looks beyond redness alone to understand tear film instability, ocular surface disease, and the real-world visual symptoms affecting daily life.

Dry eye disease is not simply a lack of tears. It is a chronic condition of the ocular surface — driven by tear film instability, inflammation, meibomian gland dysfunction, or environmental exposure — that causes persistent discomfort, visual fluctuation, and in some cases, measurable damage to the surface of the eye. Effective management requires identifying which component is driving your symptoms, not simply prescribing lubricant drops.


Dry Eye Disease in Gurgaon: When Your Eyes Never Feel Quite Right

Dry eye is one of the most undertreated conditions in ophthalmology, not because treatment doesn’t exist, but because patients are routinely told that what they are experiencing is minor.

It is not minor. Eyes that burn, sting, water excessively, feel gritty by afternoon, blur when you are tired, or ache after two hours of screen time are not eyes that are functioning normally. And patients who have been handed a bottle of artificial tears and sent home, sometimes repeatedly, know exactly how inadequate that response feels.

Dry eye disease has a pathophysiology. It has subtypes. It has measurable signs. And it has a treatment pathway that goes considerably further than lubricant drops, when it is managed by someone who understands the full picture.

This practice takes dry eye seriously. Because your eyes deserve to feel comfortable.


What Dry Eye Disease Actually Is

Dry eye disease is a multifactorial condition of the ocular surface. The tear film — the thin, layered fluid that coats your eye with every blink — requires three components to function correctly: an aqueous layer produced by the lacrimal gland, a lipid layer produced by the meibomian glands in your eyelids, and a mucin layer produced by goblet cells on the ocular surface.

When any of these components fails, the tear film becomes unstable. The surface dries between blinks. Inflammation follows. And a self-reinforcing cycle begins — surface damage drives more inflammation, which drives more surface damage.

Understanding which component is failing is the starting point of effective treatment.

Evaporative dry eye and meibomian gland dysfunction

The most common form of dry eye in urban Indian populations is evaporative — driven by meibomian gland dysfunction (MGD). The meibomian glands line the upper and lower eyelids and produce the lipid layer that prevents tear evaporation. When these glands become blocked or atrophied, tears evaporate too quickly regardless of how much aqueous is produced.

MGD is dramatically worsened by screen use, air conditioning, low humidity environments, and contact lens wear — the exact conditions that define urban professional life in Gurgaon and Delhi NCR.

Aqueous deficient dry eye

In some patients — particularly post-menopausal women, patients with autoimmune conditions like Sjögren’s syndrome, and those on certain systemic medications — the lacrimal gland simply does not produce enough aqueous tears. This form requires a different treatment approach and often warrants systemic investigation.

Mixed dry eye

Many patients have both components — inadequate lipid and inadequate aqueous — compounded by surface inflammation. These patients are frequently the ones who have tried multiple lubricant drops without relief, because no single drop addresses the full picture.

Ocular surface inflammation

Chronic inflammation is both a cause and a consequence of dry eye disease. In patients with significant inflammation, lubricant drops alone will never be sufficient. Anti-inflammatory therapy — whether topical cyclosporine, lifitegrast, or short-course steroids — is a necessary component of management.


Why Dry Eye Is Worse Than Ever in Urban India

The epidemiology of dry eye has shifted dramatically in the last decade. What was once considered a condition of older women is now presenting across all ages, genders, and occupations — and the drivers are environmental and behavioural.

Risk FactorWhy It Matters
Screen timeBlink rate drops by up to 60% during screen use; tear film destabilises
Air conditioningLow humidity environments accelerate tear evaporation
Contact lens wearDisrupts tear film distribution and lipid layer integrity
Glaucoma dropsPreservatives in long-term glaucoma medications cause surface toxicity
Post-surgical drynessLASIK, cataract surgery, and other procedures transiently or persistently disrupt corneal nerves and surface
Hormonal changesMenopause significantly reduces aqueous and lipid tear production
Antihistamines and antidepressantsMany systemic medications reduce tear secretion as a side effect
Urban air pollutionParticulate matter and pollutants directly damage the ocular surface

Gurgaon sits at the intersection of several of these factors simultaneously — screen-intensive professional culture, year-round air conditioning, high ambient pollution, and one of the highest LASIK procedure rates in North India.


What We Often Miss in Dry Eye Management

Meibomian gland dysfunction goes unexamined. Most dry eye consultations do not include eyelid margin assessment or meibomian gland expression. Without examining the glands, evaporative dry eye — the most common subtype — is routinely misidentified as aqueous deficiency and treated with the wrong drops.

Post-surgical dryness is underestimated. Dry eye after LASIK, SMILE, or cataract surgery can persist for twelve to eighteen months, and in some patients becomes a chronic condition. Patients are frequently told their symptoms will resolve on their own — without a structured management plan being put in place.

Glaucoma patients’ ocular surface is neglected. Patients on long-term preserved glaucoma drops develop surface toxicity at a rate that is well-documented in the literature but poorly addressed in clinical practice. If you have glaucoma and dry eye, the two conditions must be managed together.

Inflammation is not addressed. Patients cycling through artificial tear brands without improvement almost always have a significant inflammatory component. Without anti-inflammatory therapy, the cycle does not break.

Screen habits are not discussed. Behavioural modification — structured blink exercises, the 20-20-20 rule, screen positioning, humidifier use — forms a critical part of dry eye management that is rarely covered in a brief consultation.


What to Expect at a Dry Eye Consultation

A structured dry eye assessment goes beyond asking how your eyes feel and prescribing drops.

At this practice, assessment includes tear film evaluation, tear break-up time, meibomian gland assessment, corneal and conjunctival staining, and a detailed history of your screen habits, contact lens use, surgical history, and systemic medications. Where indicated, additional investigations including meibography — imaging of the meibomian glands — may be recommended.

Treatment is then built around your specific subtype and severity. This may include targeted lubricants, lipid-containing drops, warm compress and lid hygiene protocols, anti-inflammatory therapy, punctal plugs, or in-office procedures. You will leave with a structured plan — not a single bottle and a follow-up in six months.


Dry Eye Topics Covered in This Practice

Understanding Dry Eye

Specific Populations

Treatment and Management

  • Dry eye drops: which one is right for your subtype
  • Anti-inflammatory treatment for chronic dry eye
  • Punctal plugs: what they are and when they help
  • Warm compresses and lid hygiene: the evidence base
  • Treatment-resistant dry eye: what to do when drops aren’t enough

Second Opinions

  • Getting a dry eye second opinion in Gurgaon
  • When dry eye symptoms mean something more serious

Here is what you can read, to understand your symptoms

Dry Eye Is Not Just Dryness

Dry Eye Specialist in Gurgaon

Natural remedies

Omega-3 and Dry Eye

Why Do Women Get Dry Eye More Often?

Women’s Eye Health

Why Dry Eye Is Worse in Air Conditioning and on Flights

Screen time and fatigue

Why Your Eyes Water Constantly

Diabetes and Eye Complications

Eye Health After 60

Eye Care During Pregnancy

Dry Eye

Autologous Serum Eye Drops for Severe

Dry Eye

Dry Eye Disease: A Chronic Eye Disease

Dry Eyes: Natural Remedies

Dry Eyes: Tips to Soothe Sore Eyes

Managing Glaucoma Eye Drop Side Effects

Menopause and Dry Eyes

Ocular GVHD

PROWL: Listening to LASIK Patients

Why Are Your Dry Eye Drops Not Working

Why Dry Eye Symptoms and Tests Don’t Match


When to Come In

Book a dry eye assessment if:

  • Your eyes burn, sting, or feel gritty — especially by afternoon or after screen use
  • Your vision fluctuates and clears when you blink
  • Your eyes water excessively — paradoxical tearing is a common dry eye sign
  • You wear contact lenses and your comfortable wearing time has reduced
  • You have had LASIK, SMILE, or cataract surgery and your eyes have not felt normal since
  • You are on long-term glaucoma drops and your eyes feel uncomfortable
  • You have been using lubricant drops for months without meaningful relief
  • You have been diagnosed with an autoimmune condition and have eye symptoms

Dry eye is a chronic condition — but it is a manageable one. The patients who do best are those who receive an accurate subtype diagnosis early and follow a structured management plan. Lubricant drops are a starting point, not a solution.


Frequently Asked Questions

What is the best treatment for dry eye disease?

There is no single best treatment — because dry eye has multiple subtypes that require different approaches. Evaporative dry eye from meibomian gland dysfunction is treated with warm compresses, lid hygiene, and lipid-containing drops. Aqueous deficient dry eye may require anti-inflammatory therapy and punctal plugs. Inflammatory dry eye requires targeted anti-inflammatory treatment. Accurate subtype diagnosis is the essential first step.

Can dry eye be cured permanently?

In most patients, dry eye disease is a chronic condition that requires ongoing management rather than a one-time cure. However, with consistent and correctly targeted treatment, the majority of patients achieve significant and sustained relief. Some causes — such as post-surgical dryness or medication-related dryness — may resolve once the underlying cause is addressed.

Why do my eyes water if I have dry eye?

Paradoxical tearing — excessive watering in a dry eye patient — is one of the most common and confusing symptoms of dry eye disease. When the ocular surface becomes irritated from tear film instability, the lacrimal gland produces reflex tears as a protective response. These reflex tears do not replace the stable tear film and do not relieve the underlying dryness.

Is dry eye worse in Gurgaon and Delhi NCR?

Yes. Urban environments with high screen use, year-round air conditioning, significant ambient pollution, and low outdoor humidity create conditions that are particularly hostile to tear film stability. Gurgaon’s professional demographic — high screen exposure, frequent air travel, contact lens use — compounds these environmental factors significantly.

Can dry eye damage my vision permanently?

In mild to moderate dry eye, vision fluctuates but does not sustain permanent damage. In severe, untreated dry eye — particularly in aqueous deficient conditions or after significant surface damage — corneal scarring and permanent visual reduction can occur. This is rare but preventable with appropriate management.

I have been using artificial tears for months with no improvement. What should I do?

This is the most common presentation at a dry eye second opinion consultation. Patients cycling through lubricant drop brands without relief almost always have either an unaddressed inflammatory component, undertreated meibomian gland dysfunction, or a subtype mismatch between the drops they are using and the dry eye they actually have. A structured reassessment — including eyelid examination and tear film evaluation — usually identifies the gap quickly.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


Walk-In Eye Consultation in Gurgaon

If your eye suddenly hurts, your vision has changed, or something simply does not feel right, you do not need to wait for a scheduled appointment. Walk-in eye consultations are welcome, and for emergencies, immediate assessment takes priority over everything else, explains Dr Shibal Bhartiya.

That said, booking ahead means shorter waiting times and a more relaxed, thorough examination. This page explains both options so you can make the right call for your situation.

Here’s all you need to understand about Walk-In Eye Consultation in Gurgaon: When to Come In Without an Appointment


Walk-In Consultations Are Welcome

Whether you have a sudden concern, are visiting Gurgaon temporarily, or simply could not find a convenient appointment slot, walk-in patients are seen at the clinic. No prior referral is needed.

For non-urgent concerns, walk-ins are accommodated in the order of arrival alongside scheduled patients. You may wait longer than someone who has booked in advance, but you will be seen.

For emergencies, you do not wait. Eye emergencies are assessed immediately regardless of the appointment schedule.


Eye Emergencies: Come In Right Away

Some symptoms cannot wait — not for an appointment, not for tomorrow, not until the weekend is over. If you experience any of the following, come in the same day:

  • Sudden loss of vision in one or both eyes, even if it seems to be improving
  • Severe eye pain, especially if accompanied by nausea or vomiting
  • Flashes of light or a sudden shower of floaters — new, not longstanding
  • A shadow, curtain, or dark area appearing in any part of your vision
  • Eye injury — chemical splash, foreign body, blunt trauma, or penetrating injury
  • Sudden double vision that is new and persistent
  • Red eye with pain and reduced vision — particularly with coloured haloes around lights
  • Eye pain after a procedure or surgery

These are not symptoms to monitor at home. Delay in conditions like retinal detachment, acute angle-closure glaucoma, or chemical injury directly worsens the outcome. Come in, call ahead if you can — but come in.

📞 +91 88826 38735


Why Booking an Appointment Helps

A walk-in visit gets you seen. A booked appointment gets you the most from your visit.

Here is why it makes a difference:

Shorter waiting time. Scheduled patients are slotted into the OPD timetable. Walk-in patients are fitted around them. On busy clinic days, this can mean a meaningful wait — sometimes one to two hours. Booking ahead eliminates most of that.

Time to prepare your records. When an appointment is booked, you have the opportunity to upload previous prescriptions, reports, or investigation results before you arrive. This allows the consultation to begin with context — not from scratch. The more complex your history, the more this matters.

Investigations can be planned in advance. Certain tests — visual fields, OCT, corneal topography, gonioscopy — take time to perform and interpret. When your visit is planned, the right investigations can be sequenced efficiently within your consultation slot.

More focused consultation time. A scheduled visit, with records reviewed in advance, means the consultation can go deeper. For conditions like glaucoma, where the history of pressure readings, field tests, and disc changes over time is as important as the examination today, this context is clinically significant.

Second opinions benefit most from preparation. If you are coming for a second opinion on a diagnosis or a treatment plan, sending records ahead transforms the consultation. It becomes a review of your full picture — not a repeat of tests already done elsewhere.


What to Bring to a Walk-In or Scheduled Visit

Whether you book ahead or walk in, bring whatever you have:

  • Current glasses or contact lenses (wear them if you normally do)
  • Previous glasses prescriptions
  • Any eye investigation reports — OCT, visual fields, corneal topography
  • List of current medications, including eye drops
  • Any letters or discharge summaries from previous ophthalmologists
  • Your phone, pre-loaded with any photographs of symptoms if relevant

If you have none of these, that is fine. The examination begins with what is present.


How to Book an Appointment

Booking takes less than two minutes.

Call or WhatsApp: +91 88826 38735

Online: www.drshibalbhartiya.com — use the appointment or contact form to request a slot, or upload reports for review before you arrive.

Appointments are available during OPD hours at Marengo Asia Hospitals, Sector 56, Gurugram. For teleconsultation — if you are outside Gurgaon or prefer a remote review of your reports first — this can also be arranged through the website.


Frequently Asked Questions

Can I walk in for an eye examination without a referral?

Yes. No referral is required for a walk-in consultation. You will be registered at reception and seen in order of arrival, alongside scheduled patients.

How long will I wait as a walk-in patient?

This varies by how busy the OPD is on that day. On quieter days, the wait may be under 30 minutes. On busy days, it can be longer. Booking an appointment is the most reliable way to reduce waiting time.

What counts as an eye emergency?

Any sudden change in vision, severe eye pain, new flashes or floaters, a shadow in your vision, eye injury, or red eye with pain and reduced vision. These are emergencies. Walk in immediately — do not wait for an appointment.

Can I upload my reports before a walk-in visit?

Yes. Even if you have not booked an appointment, you can upload reports through the website in advance so they are available at the time of your consultation.

Is teleconsultation available for patients outside Gurgaon?

Yes. For patients who are not in Gurgaon, a teleconsultation can be arranged to review reports and investigations remotely. Contact the clinic through the website or by phone to schedule this.

What should I do if I arrive and my symptoms have worsened?

Tell the reception staff immediately. Any worsening of symptoms — especially vision loss, increasing pain, or new double vision — changes your priority. You will be assessed promptly.


Visit Us

Dr Shibal Bhartiya — Glaucoma & Ophthalmology Clinic Marengo Asia Hospitals, Sector 56, Gurugram, Haryana — 122011

📞 +91 88826 38735 🌐 www.drshibalbhartiya.com

Walk-ins welcome. Appointments preferred. Emergencies always first.


About the Author

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

PubMed Profile | Google Scholar | ResearchGate | ORCID

Helped by this article? Leave a Google review — it helps other patients find reliable eye care.

📋 Upload your reports for review before your appointment at www.drshibalbhartiya.com

📞 +91 88826 38735

Dry Eye Is Not Just Dryness: Managing It as a Chronic Condition

Dry eye disease is a chronic condition caused by an unstable or insufficient tear film. It does not go away with occasional lubricating drops. Left unmanaged, it causes progressive surface damage, worsening discomfort, and, in some cases, permanent corneal scarring. Long-term management, not short-term relief, is the correct approach, says Dr Shibal Bhartiya.

Dry eye is one of the most common eye conditions seen in clinical practice. Most patients manage it with over-the-counter drops and expect it to resolve. It rarely does.

Dry eye disease is a multifactorial condition of the ocular surface. The tear film is complex. When it breaks down, the result is inflammation, epithelial damage, and a cycle that perpetuates itself without targeted treatment.

Understanding dry eye as a chronic disease changes how patients manage it, and how much vision and comfort they can preserve over time.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

What Is Dry Eye Disease?

Dry eye disease (DED) is defined by the TFOS DEWS II report as a multifactorial disease of the ocular surface. It involves loss of tear film stability and is accompanied by symptoms and signs of varying severity.

The tear film has three layers: a mucin layer anchoring tears to the eye surface, an aqueous (watery) layer providing nutrients and oxygen, and a lipid (or oil) layer produced by the meibomian glands that prevents evaporation. A problem in any one layer causes disease.

Two Main Types of Dry Eye

Aqueous Deficient Dry Eye

This type involves insufficient tear production. The lacrimal gland does not produce enough aqueous fluid. It is common in post-menopausal women, patients with Sjogren’s syndrome, and those on antihistamines, antidepressants, or blood pressure medications.

Evaporative Dry Eye

This is the more common type, accounting for roughly 85 percent of all dry eye cases. Meibomian gland dysfunction (MGD) is the primary cause. Blocked or abnormal meibomian glands fail to secrete a healthy lipid layer, and tears evaporate too quickly.

Many patients have both types simultaneously. Treatment must address the dominant mechanism.

FeatureAqueous Deficient DEDEvaporative DED
Primary causeReduced lacrimal gland outputMeibomian gland dysfunction
Proportion of casesApproximately 15%Approximately 85%
Key risk factorsSjogren’s, medications, ageScreen use, blepharitis, rosacea
Tear break-up timeReducedVery short (under 5 seconds)
Treatment focusTear supplementationLid hygiene, heat, omega-3
Inflammation presentOften yesYes, secondary

Why Dry Eye Becomes Chronic

The tear film and ocular surface exist in a feedback loop. When the tear film is unstable, the surface desiccates. This triggers inflammation. Inflammation damages goblet cells and lacrimal tissue. Damaged tissue produces less stable tears. The cycle continues.

Without breaking this cycle, not just lubricating the surface, dry eye worsens over months and years. This is why patients who only use drops often find their symptoms returning or intensifying.

Chronic untreated dry eye can cause corneal epithelial breakdown, punctate keratitis, subepithelial scarring, and, in severe cases, corneal ulcers. These are not trivial outcomes.

Risk Factors That Drive Progression

  • Screen use of more than four hours daily reduces blink rate and increases evaporation.
  • Contact lens wear disrupts the tear film and accelerates meibomian gland dropout.
  • Hormonal changes — especially menopause — reduce lacrimal and meibomian secretions.
  • Systemic medications including antihistamines, SSRIs, diuretics, and isotretinoin reduce tear production.
  • Autoimmune conditions such as rheumatoid arthritis, lupus, and thyroid disease affect the lacrimal gland.
  • Rosacea is a strong risk factor for meibomian gland dysfunction and is frequently undiagnosed.
  • Air conditioning, low humidity, and air travel accelerate tear evaporation.
  • Prior LASIK or refractive surgery causes corneal nerve damage and temporarily reduces reflex tearing.

How Dry Eye Is Diagnosed

Diagnosis requires more than a symptom questionnaire. A structured assessment includes the OSDI (Ocular Surface Disease Index) score, tear break-up time (TBUT), Schirmer’s test, corneal and conjunctival staining with fluorescein and lissamine green, and meibomian gland evaluation.

Meibography — infrared imaging of the meibomian glands — shows the degree of gland dropout and guides treatment intensity. Patients with significant gland loss need early and aggressive intervention to preserve remaining function.

Tear osmolarity testing measures the salt concentration of tears. Elevated osmolarity confirms tear film instability and is useful for monitoring treatment response objectively.

Diagnostic TestWhat It MeasuresClinical Significance
TBUT (tear break-up time)Tear film stabilityUnder 10 seconds is abnormal
Schirmer’s testAqueous tear productionUnder 10 mm in 5 min is reduced
Corneal fluorescein stainingEpithelial surface damageConfirms active disease severity
MeibographyMeibomian gland structure and dropoutGuides long-term prognosis
Tear osmolarityTear salt concentrationOver 308 mOsm/L confirms DED
OSDI scoreSymptom burdenTracks treatment response over time

Treatment: A Layered Approach

Dry eye treatment is not one-size-fits-all. It is matched to disease type, severity, and the dominant mechanism driving symptoms.

Step 1: Environmental and Behavioural Changes

Reduce screen time or use the 20-20-20 rule — every 20 minutes, look at something 20 feet away for 20 seconds. Increase blink frequency consciously. Use a humidifier in air-conditioned environments. Wear wraparound glasses in wind and dry air.

Step 2: Lid Hygiene and Warm Compresses

Warm compresses applied for 10 minutes daily soften meibomian secretions and improve gland expressibility. Lid massage after warming clears blocked glands. Lid scrubs with baby shampoo or commercially prepared wipes reduce bacterial load on the lid margin.

Consistency matters more than intensity. Daily lid hygiene over months produces measurable improvement in tear film quality.

Step 3: Lubricating Eye Drops

Not all lubricants are equivalent. Drops containing carboxymethylcellulose, sodium hyaluronate, or polyethylene glycol provide longer contact time. Preservative-free formulations are essential for patients using drops more than four times daily — preservatives accelerate the surface damage they are meant to relieve.

Gel formulations and ointments provide longer relief but blur vision temporarily and are best used at night.

Step 4: Omega-3 Fatty Acid Supplementation

Omega-3 supplements — particularly EPA and DHA from fish oil or re-esterified triglyceride formulations — improve meibomian secretion quality and reduce ocular surface inflammation. The DREAM study showed that high-dose omega-3 did not significantly outperform olive oil placebo, but clinical practice and other evidence support a role for supplementation in evaporative dry eye.

A daily dose of 2000 to 3000 mg EPA+DHA for at least three months is typically recommended.

Step 5: Anti-Inflammatory Therapy

When inflammation is driving symptoms, lubricants alone are insufficient. Cyclosporine eye drops (0.05% or 0.1%) reduce T-cell mediated inflammation on the ocular surface and restore goblet cell density over three to six months of use. They are not a quick fix — patients must be counselled on the time course.

Lifitegrast 5% is an integrin antagonist that blocks the LFA-1 to ICAM-1 interaction driving ocular surface inflammation. It offers symptom relief somewhat faster than cyclosporine.

Short-term topical corticosteroids are used to rapidly break the inflammatory cycle, particularly at disease onset or during flares. They are not for long-term use.

Step 6: Procedural Treatments

Intense Pulsed Light (IPL) therapy targets abnormal blood vessels on the lid margin that drive meibomian gland inflammation. It also applies heat that melts obstructed meibum. Multiple sessions spaced three to four weeks apart produce sustained improvement in many patients with moderate to severe MGD.

Thermal pulsation devices (LipiFlow) deliver controlled heat and pressure to the inner eyelid to express inspissated meibum. The effect can last six to twelve months and is repeatable.

Punctal plugs block the drainage of tears from the ocular surface. They are appropriate for aqueous deficient dry eye when lubrication alone is inadequate. Dissolvable collagen plugs are trialled before permanent silicone plugs are inserted.

TreatmentBest ForTime to Effect
Preservative-free lubricantsAll types, daily useImmediate symptom relief
Lid hygiene + warm compressesEvaporative / MGD4 to 8 weeks of daily use
Omega-3 supplementationEvaporative / MGD8 to 12 weeks
Cyclosporine dropsInflammatory DED3 to 6 months
Lifitegrast dropsInflammatory DED2 to 4 weeks for symptoms
IPL therapyModerate to severe MGDAfter 3 to 4 sessions
Punctal plugsAqueous deficient DEDDays to weeks

Monitoring Dry Eye Over Time

Dry eye is managed, not cured. Follow-up visits every three to six months allow the specialist to assess treatment response, adjust the regimen, and monitor for corneal surface deterioration.

Objective tests — TBUT, osmolarity, staining scores — are more reliable than symptoms alone. Patients often adapt to chronic discomfort and underreport severity. Imaging guides clinical decisions even when symptoms appear stable.

Meibomian gland dropout is irreversible. Preventing further loss is the priority once significant atrophy is identified.

Dry Eye and Systemic Disease

Dry eye is frequently a signal of systemic disease. Sjogren’s syndrome, rheumatoid arthritis, lupus, thyroid eye disease, and graft-versus-host disease all affect the ocular surface. Patients with unexplained severe dry eye — particularly younger women — should be evaluated for autoimmune conditions.

Conversely, patients already diagnosed with these conditions should have formal ocular surface assessments. Dry eye in this context needs co-management with the treating physician.

When to See a Glaucoma and Ocular Surface Specialist

Many patients with dry eye also have glaucoma or glaucoma suspect status. Glaucoma drops — particularly those with preservatives — are a significant cause of ocular surface disease. The benzalkonium chloride (BAK) in most preserved glaucoma drops is toxic to goblet cells and the corneal epithelium.

If you use glaucoma drops and have dry eye symptoms, your specialist needs to review both conditions together. Switching to preservative-free formulations or fixed-combination drops can reduce surface toxicity without compromising IOP control.

A specialist with expertise in both conditions can optimise your glaucoma management while actively protecting the ocular surface.

Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.

Frequently Asked Questions

Can dry eye disease be cured?

There is no permanent cure for most forms of dry eye disease. However, it can be very well controlled with the right treatment strategy. Many patients achieve significant symptom relief and stable ocular surface health with long-term management.

Are lubricating drops enough to treat dry eye?

For mild disease, lubricants provide adequate relief. For moderate to severe dry eye — or evaporative disease driven by meibomian gland dysfunction — drops manage symptoms but do not address the underlying cause. Lid hygiene, anti-inflammatory therapy, and sometimes procedural treatment are needed.

How do I know if my dry eye is getting worse?

Worsening symptoms, increased frequency of drop use, morning grittiness, light sensitivity, and fluctuating vision are all signs of progression. Objective worsening on TBUT, staining, or osmolarity testing confirms it. Do not wait for significant discomfort before seeking review.

Can diet help with dry eye?

Yes. Omega-3 fatty acids from oily fish, flaxseed, and walnuts support meibomian gland secretion quality. Adequate hydration matters. Foods high in omega-6 fatty acids and processed vegetable oils may worsen inflammation. A Mediterranean-style diet is broadly supportive of ocular surface health.

Is dry eye related to screen use?

Yes. Screen use reduces spontaneous blink rate from a normal 15 to 17 blinks per minute to as few as 3 to 5 blinks per minute. Reduced blinking causes tear film instability and accelerates evaporation. Deliberate blinking exercises and regular screen breaks are first-line recommendations for screen-related dry eye.

Can I wear contact lenses if I have dry eye?

Some patients with well-managed mild dry eye can wear contacts with modifications — daily disposable lenses, lubricating drops compatible with contact wear, and reduced wearing time. Patients with moderate to severe dry eye are advised to avoid contact lenses until surface health is restored. Scleral lenses are a specialist option for severe cases.

Does menopause cause dry eye?

Yes. Oestrogen and androgen deficiency after menopause reduces both aqueous and meibomian secretion. Dry eye prevalence in post-menopausal women is significantly higher than in age-matched men. Hormone replacement therapy has a complex relationship with dry eye — some studies show benefit, others do not. Ocular surface assessment after menopause is advisable.

Book a Dry Eye Assessment in Gurgaon

Dry eye responds best to early, structured management. A thorough ocular surface assessment — including meibography, osmolarity, and staining — identifies the cause and guides a treatment plan that works long-term.

If you are using lubricating drops daily and still struggling, the underlying mechanism has not yet been addressed. A specialist review changes that.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read More

Basics of Dry Eye

Dry Eye Second Opinion

Dry Eye: A Chronic Disease

Why Do Women Get Dry Eye More Often?

Menopause and Dry Eye

Dry Eyes: Natural Remedies

Dry Eyes: Tips to Soothe Sore Eyes

Why Dry Eye Is Worse in Air Conditioning and on Flights

Why Vision Becomes Blurred After Reading or Screen Use

Screen Fatigue

Why Your Eyes Water Constantly

Omega-3 and Dry Eye

Why Are Your Dry Eye Drops Not Working

Autologous Serum Eye Drops for Severe Dry Eye

Why Do Women Get Dry Eye More Often?

Women develop dry eye disease two to three times more often than men. The primary reasons are hormonal fluctuation across the reproductive lifespan, oestrogen, progesterone, and androgen changes at puberty, during pregnancy, on oral contraceptives, and at menopause. This is combined with a higher prevalence of autoimmune conditions that directly damage the lacrimal and meibomian glands. Most women wait years before receiving a correct diagnosis because dry eye is still widely misattributed to screen time, pollution, or ageing alone, explains Dr Shibal Bhartiya.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Dry eye in women is not a minor inconvenience. It is a chronic, progressive ocular surface disease with documented links to autoimmune conditions, hormonal milestones, and inadequate medical recognition. Women who dismiss their symptoms or accept “it’s just dryness” as a complete answer are at risk of progressive corneal damage and deteriorating quality of life.


Why Women Are at Higher Risk: The Evidence

Hormones Drive Tear Film Biology

The tear film has three layers: aqueous, mucin, and lipid. All three are hormone-sensitive.

Oestrogen increases aqueous tear production at physiological levels but disrupts it when it drops sharply. Perimenopausal and postmenopausal women experience the steepest fall in oestrogen, which is why dry eye prevalence rises sharply after age 50.

Androgens are essential for meibomian gland function. The meibomian glands produce the lipid layer that prevents tear evaporation. Women have lower androgen levels than men throughout life, and androgen levels fall further at menopause. This makes women structurally more vulnerable to meibomian gland dysfunction, the most common cause of evaporative dry eye.

Oral contraceptives suppress androgen levels. Studies consistently show higher rates of dry eye in women using combined oral contraceptives compared to non-users. Contact lens discomfort and dry eye symptoms worsen during OCP use and often improve after stopping.

Pregnancy creates rapidly shifting hormonal states. Many women notice significant tear film changes during pregnancy and breastfeeding, including both dry eye and, paradoxically, temporary improvement in some pre-existing conditions.


Autoimmune Conditions: The Underrecognised Connection

Autoimmune diseases are three times more common in women than in men. Several of them directly attack the lacrimal glands, the meibomian glands, and the conjunctival goblet cells that produce mucin.

Sjögren’s Syndrome

Sjögren’s syndrome is the most important autoimmune cause of dry eye in women. It targets exocrine glands: primarily the lacrimal and salivary glands, causing severe aqueous-deficient dry eye and dry mouth.

Sjögren’s affects an estimated 0.5–1% of the population, with a 9:1 gender (F:M) ratio. Most patients are diagnosed in their 40s and 50s, but symptoms often begin a decade earlier. The average time from first symptom to diagnosis is 4–7 years. A delay that leads to corneal surface damage, infection risk, and preventable vision loss.

Signs that raise suspicion for Sjögren’s in a dry eye patient:

  • Severe aqueous-deficient dry eye not responding to standard lubricants
  • Associated dry mouth, difficulty swallowing, or recurrent dental caries
  • Parotid gland enlargement
  • Joint pain or fatigue without clear cause
  • Positive anti-SSA/Ro or anti-SSB/La antibodies

If Sjögren’s is suspected, referral to a rheumatologist is appropriate alongside ophthalmic management.

Rheumatoid Arthritis

Rheumatoid arthritis (RA) has a 3:1 female predominance. Dry eye occurs in 10–35% of RA patients due to lacrimal gland infiltration by inflammatory cells. Scleritis and peripheral ulcerative keratitis are both sight-threatening conditions, and also associated with RA. Both require an urgent specialist review.

Systemic Lupus Erythematosus (SLE)

SLE predominantly affects women of reproductive age. Dry eye is common in lupus, occurring through autoimmune lacrimal gland damage and secondary Sjögren’s overlap. Hydroxychloroquine, used to treat SLE, can cause retinal toxicity and requires regular retinal screening, a point often missed by rheumatologists managing these patients.

Thyroid Disease

Thyroid eye disease (TED), particularly Graves’ disease and Hashimoto’s thyroiditis, is 5–8 times more common in women. It also causes proptosis, exposure keratopathy, and severe dry eye through lagophthalmos. Even in the absence of overt TED, hypothyroid patients frequently report dry eye symptoms related to reduced tear production.


Life Stages When Dry Eye Worsens in Women

Life StageHormonal ChangeDry Eye Risk
Oral contraceptive useSuppressed androgensMeibomian gland dysfunction, contact lens intolerance
PregnancyOestrogen surge, then fallVariable; improvement or worsening
Postpartum / breastfeedingProlactin high, oestrogen lowDry eye common; often unrecognised
PerimenopauseOestrogen and androgen fluctuationSignificant dry eye onset or worsening
MenopauseSharp oestrogen and androgen fallHighest risk period; most common new presentation
Post-menopauseSustained low androgen and oestrogenChronic evaporative dry eye

The Pattern of Delayed Diagnosis in Women

Women with dry eye symptoms are more likely than men to be dismissed, undertreated, or given incomplete diagnoses. Several patterns repeat in clinical practice.

Screen time blamed by default. Digital eye strain causes dryness through reduced blink rate, but it does not cause chronic dry eye disease. When a menopausal woman with Sjögren’s is told to “use eye drops and take breaks from screens,” the underlying condition goes untreated.

Lubricant drops prescribed without investigation. Over-the-counter lubricants manage symptoms but do not address the cause. Meibomian gland dysfunction requires warm compresses, lid hygiene, omega-3 supplementation, and sometimes in-office procedures. Aqueous-deficient dry eye from Sjögren’s requires immunosuppressive management, not just lubricants.

Autoimmune investigation not initiated. Many women with dry eye are never asked about joint pain, dry mouth, fatigue, or rashes. The systemic connection between dry eye and autoimmune disease is systematically underinvestigated in routine eye care settings.

Menopausal symptoms normalised. Women are often told that dry eye is “just part of menopause” without being told that effective, targeted treatments exist.


What We Often Miss

The meibomian glands can be imaged directly. Meibography, infrared imaging of the eyelid glands, shows gland dropout, which is irreversible. In a woman presenting with dry eye at menopause, meibography identifies whether there is significant structural gland loss that will not respond to lubricants alone.

Tear film osmolarity measurement distinguishes dry eye severity more reliably than symptom scores. A value above 308 mOsm/L in either eye, or an inter-eye difference greater than 8 mOsm/L, is diagnostic of dry eye disease.

Corneal staining with fluorescein and lissamine green maps surface damage that is invisible to the patient until it is advanced. Women who have had dry eye for years without adequate treatment frequently show significant staining they were unaware of.


What to Expect from a Thorough Dry Eye Evaluation

A complete evaluation for dry eye in women should include:

History: Duration, severity, pattern of symptoms (worse in the morning vs evening), contact lens use, OCP or HRT use, menopausal status, autoimmune history, medications, thyroid history.

Examination: Visual acuity, slit-lamp assessment of lid margins and meibomian gland orifices, tear meniscus height, fluorescein tear break-up time, corneal and conjunctival staining.

Investigations (where indicated): Tear film osmolarity, meibography, Schirmer test, inflammatory markers (for autoimmune workup), thyroid function tests, ANA, anti-SSA/SSB.

Treatment options tailored to cause:

  • Meibomian gland dysfunction: warm compresses, lid massage, omega-3 fatty acids, tetracycline antibiotics, intense pulsed light therapy
  • Aqueous-deficient dry eye: preservative-free lubricants, cyclosporine eye drops, punctal plugs, autologous serum drops
  • Autoimmune-driven dry eye: systemic immunosuppression in collaboration with rheumatology
  • Hormonal dry eye: androgen eye drops (under investigation), HRT discussion with gynaecology for menopausal patients

When to See a Specialist

Seek specialist review without delay if you notice any of the following. Persistent burning, foreign body sensation, or visual fluctuation that has lasted more than three months. Dry eye symptoms alongside dry mouth, joint pain, fatigue, or rashes. Contact lens intolerance developing without clear cause. Increasing light sensitivity or eye redness. Any history of autoimmune disease with new onset eye discomfort. Symptoms worsening on oral contraceptives or at the time of menopause.


What This Means for You

Dry eye in women is frequently undertreated because it is frequently underevaluated. The hormonal and autoimmune drivers are real, documented, and manageable: but only if they are looked for. A woman with dry eye deserves a full diagnostic assessment, not a bottle of artificial tears and an instruction to blink more.

If your symptoms have been present for more than a few months, have not responded to lubricants, or are accompanied by any systemic symptoms, a structured review with a specialist who takes the full picture seriously is appropriate.


Frequently Asked Questions

Can hormonal changes cause dry eye?

Yes. Oestrogen, progesterone, and androgen fluctuations across the reproductive lifespan directly affect tear production and meibomian gland function. Dry eye is particularly common at perimenopause and menopause due to falling oestrogen and androgen levels.

Is dry eye a symptom of Sjögren’s syndrome?

Dry eye is the cardinal ocular feature of Sjögren’s syndrome. If dry eye is severe, fails to respond to standard lubricants, or is accompanied by dry mouth or systemic symptoms, Sjögren’s must be considered and investigated with blood tests and specialist referral.

Do oral contraceptive pills cause dry eye?

Combined oral contraceptives suppress androgen levels, which impairs meibomian gland function. Contact lens intolerance and dry eye symptoms are more common in OCP users. Symptoms often improve after stopping the pill.

Should I see an eye doctor or a rheumatologist for autoimmune dry eye?

Both. Autoimmune dry eye requires co-management. An ophthalmologist assesses and treats the ocular surface. A rheumatologist investigates and manages the systemic condition. The two must communicate, particularly for conditions like Sjögren’s, RA, and lupus.

Can dry eye damage my vision permanently?

Yes. Untreated severe dry eye causes corneal epithelial breakdown, scarring, and secondary infection. These changes can affect vision permanently. This is why dry eye should not be dismissed as a minor complaint, particularly in women with underlying autoimmune or hormonal risk factors.


Speak to a Specialist

If you have been told your dry eye is “just dryness” and it has not improved, a structured evaluation is the right next step. A second opinion from a specialist who will assess the full hormonal, autoimmune, and ocular picture gives you the clarity to make better decisions about your care.

📍 Dr Shibal Bhartiya — Marengo Asia Hospitals, Gurugram 📞 +91 88826 38735 | 🌐 www.drshibalbhartiya.com


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Dry Eye Specialist in Gurgaon

Dr Shibal Bhartiya sees dry eye patients in Gurgaon at Marengo Asia Hospitals, Sector 56. She is fellowship-trained, evidence-based, and focused on finding the root cause, not just adding more drops.

Dry eye is one of the most undertreated eye conditions in India. Many patients spend months using drops that do not work. They see multiple doctors. They get the same prescription. Nobody explains why the eye is dry, or whether the actual cause has been identified.


5 Reasons Your Dry Eye Has Not Been Treated Properly

1. Nobody typed your dry eye

Dry eye has two main forms. Aqueous-deficient dry eye means the eye does not produce enough tears. Evaporative dry eye means tears evaporate too quickly because the meibomian glands (oil glands in the eyelids) are blocked or damaged. Evaporative dry eye causes 80% of all cases. Most patients are never told which type they have.

2. You received treatment for the wrong type

Lubricating drops help symptoms temporarily. They do not unblock or repair meibomian glands. If your problem is evaporative, drops will not fix it. The surface stays irritated. The cycle continues.

3. Your glands were never imaged

Meibography is a painless scan that shows whether your meibomian glands are healthy, blocked, or atrophied. Most patients with dry eye have never had this test. Without it, treatment is guesswork.

4. A systemic cause was missed

Hormonal changes at menopause, rosacea, autoimmune conditions, and long-term medication use all affect the tear film. Dry eye in these contexts needs a different approach.

5. Your glaucoma drops were not considered

Most glaucoma drops contain preservatives (most commonly BAK, benzalkonium chloride). Daily long-term exposure damages the surface of the eye. If you have glaucoma and dry eye together, the drops may be making the surface worse. This is treatable, but only if the connection is recognised.


Who Gets Dry Eye

WhoWhyWhat to Look For
Screen-heavy professionalsReduced blinking, incomplete blinksBurning, blur at end of workday
Glaucoma patientsPreservative toxicity from daily dropsGritty irritation, red eyes, drop intolerance
Post-LASIK patientsCorneal nerve damage during surgeryPersistent dryness since surgery
Women at perimenopause / menopauseHormonal effects on gland functionWorsening dryness in mid-life
Ocular GVHD patientsImmune attack on ocular surface after transplantSevere dryness, light sensitivity
SJS / TEN patientsMucous membrane scarring from severe drug reactionExtreme dryness, chronic eye surface damage

What Doctors Often Miss

Watery eyes do not rule out dry eye. When the surface is irritated, the eye produces a reflex overflow of thin, watery tears. These tears do not lubricate. Constant watering with an underlying burning or gritty feeling is a classic dry eye presentation. Many patients are told their eyes cannot be dry because they water. This is incorrect.

Post-LASIK dryness is often undertreated. LASIK cuts corneal nerves. This reduces the eye’s ability to sense dryness and trigger reflex tearing. Post-LASIK dry eye can persist for months to years. Patients are rarely warned before surgery, and are often told it will resolve on its own. A structured evaluation is warranted if dryness has continued since the procedure.

Ocular GVHD requires specialist management. Ocular graft-versus-host disease is a serious complication of stem cell or bone marrow transplantation. It causes severe dry eye, conjunctival scarring, and progressive corneal damage. Standard lubricating drops are rarely enough. Early specialist referral changes outcomes.

SJS and TEN damage the surface permanently if untreated. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis destroy goblet cells, scar the conjunctiva, and cause some of the most severe dry eye seen in clinical practice. These patients need autologous serum drops, amniotic membrane therapy in acute phases, and long-term specialist follow-up. Standard drops do not address the underlying surface destruction.


When to Worry

See a dry eye specialist, not just a general ophthalmologist, if:

  • You have been on lubricating drops for more than three months without clear improvement
  • Your vision fluctuates or blurs after reading or screen use
  • You have glaucoma and your eyes feel gritty, red, or irritated
  • You have had LASIK and your eyes have felt dry ever since
  • You are approaching or have passed menopause and dry eye is worsening
  • You have had a bone marrow or stem cell transplant
  • You have had Stevens-Johnson Syndrome or a severe drug reaction

What This Means for You

Dry eye is usually a chronic condition. It is not something to wait out. The right diagnosis changes everything, because it changes the treatment.

At this clinic, a dry eye consultation includes meibography (gland imaging), TBUT measurement, ocular surface staining, and lid margin evaluation. These tests are done at the first visit where possible. You will leave understanding what type of dry eye you have, why the drops have not worked, and what the plan is.

Treatment depends on findings. Options include preservative-free lubricants, Intense Pulsed Light (IPL) therapy for meibomian gland dysfunction, punctal plugs, and autologous serum drops for severe or treatment-resistant disease.

If you also have glaucoma, the two conditions are managed together. Preservative-free drop formulations are used where possible. The ocular surface and the optic nerve are both tracked.


Frequently Asked Questions

My eyes water constantly. How can I have dry eye?

Watering is one of the most common symptoms of dry eye. When the surface is irritated, the eye triggers a reflex overflow of thin, watery tears. These tears do not have the right composition to lubricate the eye. Constant watering with a gritty or burning feeling underneath is a classic dry eye presentation. The two are not mutually exclusive: they are often the same problem.

I have been using drops for months. Why is nothing working?

Lubricating drops relieve symptoms temporarily. They do not treat the cause. If your meibomian glands are blocked, damaged, or inflamed, drops will not resolve that. A proper evaluation identifies whether the glands are the problem, and then treatment can be directed at the glands, not just the surface.

Is IPL therapy safe for Indian skin?

Yes. IPL settings are adjusted based on skin tone and are safe across all Fitzpatrick skin types. Settings are individualised at each session.

How many IPL sessions will I need?

Most patients need three to four sessions, spaced three to four weeks apart. Patients with mild disease sometimes respond after two. Maintenance sessions every six to twelve months sustain the benefit.

I am on glaucoma drops. Can you treat my dry eye without stopping them?

Yes. This is a common situation. The approach involves switching to preservative-free formulations where possible, treating the ocular surface directly, and monitoring both conditions carefully. Stopping glaucoma drops is rarely necessary and is never done without a careful risk assessment.

Can dry eye be cured?

Dry eye is usually a chronic condition. With the right diagnosis and treatment, most patients achieve significant and sustained symptom relief. The goal is long-term control, not a single intervention.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Related Reading

Dry Eye Specialist in Gurgaon, Haryana, India

Basics of Dry Eye

Dry Eye Second Opinion

Dry Eye: A Chronic Disease

Why Do Women Get Dry Eye More Often?

Menopause and Dry Eye

Dry Eyes: Natural Remedies

Dry Eyes: Tips to Soothe Sore Eyes

Why Dry Eye Is Worse in Air Conditioning and on Flights

Why Vision Becomes Blurred After Reading or Screen Use

Screen Fatigue

Why Your Eyes Water Constantly

Omega-3 and Dry Eye

Why Are Your Dry Eye Drops Not Working

Autologous Serum Eye Drops for Severe Dry Eye